VIC Tech Announces Formation of i-Seq Biotechnology to Pioneer Broad-Spectrum Vaccines and Therapeutics

Fayetteville, AR—VIC Tech, a leading builder of high-impact, innovative life science companies, announces the formation of i-Seq Biotechnology, a portfolio company focused on advancing novel broad-spectrum vaccines and...

Inside CU Healthcare Innovation Fund with the Director of Investments Gali Baler

Can you share a bit about your career journey and what led you to your current roles at CU Innovations? How have your previous experiences shaped your approach to innovation and investment? My career journey has been a...

VIC Tech Expands Advisory Boards with New Appointments

VIC Tech is pleased to announce the expansion of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB) with the addition of two esteemed experts. Dr. Alexandra H. Antonioli, MD, PhD, joins the MAB, and...

Maximizing Synergies Between Venture Studios and Life Science Companies

As has been thoroughly discussed by this author and others, the so-called “valley of death” is a critical barrier for the advancement of life science (therapeutic, vaccine, medical device, diagnostic and related)...

Neurexis Therapeutics Secures $3 Million NIH Grant to Advance Neuroprotective Treatment for Global Cerebral Ischemia

Aurora, CO - Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II Small Business Innovation Research (SBIR)...

VIC Foundry Secures SBIR Funding from NIDCR to Advance Vital-Dent Regenerative Pulp Therapy

VIC Foundry is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research (NIDCR) to support the commercialization of its...

Paige Jernigan Joins VIC Tech Board of Directors

FAYETTEVILLE, AR- VIC Tech is pleased to announce Paige Jernigan's appointment to its Board of Directors. Jernigan brings a wealth of experience in equity analysis, fundraising, and advisory services, with a career that...

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...

Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies

Funding Led by Tramway Venture Partners Includes Key Appointments to the Board and Accelerates the Development of High-Dose Lung Delivery Solutions. Nob Hill Therapeutics (NHT), an early-stage pulmonary medical device...

Solaris Vaccines Awarded Defense Health Agency Funding to Develop Novel Dengue Vaccine

The Defense Health Agency (DHA)—an important component of the United States Military Health System—has selected Solaris Vaccines to create a safe and effective vaccine for preventing death and disease caused by the...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix